THE EFFECTS OF ETANERCEPT AND CABERGOLINE ON ENDOMETRIOTIC IMPLANTS, UTERUS AND OVARIES IN RAT ENDOMETRIOSIS MODEL

Cihan Deniz Keleş, Birol Vural, Serdar Filiz, Fisun Vural, Gülçin Gacar, Fatma Ceyla Eraldemir, Sema Kurnaz
Journal of reproductive immunology · 2021 · vol. 146 , pp. 103340 · doi:10.1016/j.jri.2021.103340 · PMID:34139652 · W3171932476
article OA: closed CC0 ⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated the effects of etanercept and cabergoline on endometriotic implants, uterus, and ovaries in a rat model of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Cabergoline Endometriosis Endometrium Etanercept Animals Cabergoline Disease Models, Animal Drug Evaluation, Preclinical Drug Therapy, Combination Endometriosis Endometriosis Endometriosis Endometrium Endometrium Endometrium Etanercept Female Humans Ovary Ovary

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (56)

Cited by (3)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:24:31.988741+00:00
License: CC0 · commercial use OK